Therapeutics: ST6 β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1); ST6GAL2

Autoimmune disease

INDICATION: Rheumatoid arthritis (RA)

Mouse studies suggest enhancing sialylation of autoantibodies could help treat

Read the full 143 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE